Related references
Note: Only part of the references are listed.Early Clinical Observations in Prospectively Followed Patients With Fungal Meningitis Related to Contaminated Epidural Steroid Injections
Thomas M. Kerkering et al.
ANNALS OF INTERNAL MEDICINE (2013)
Fungal Outbreak Update From IDWeek
Thomas Slama et al.
CLINICAL INFECTIOUS DISEASES (2013)
Experimental Central Nervous System Aspergillosis Therapy: Efficacy, Drug Levels and Localization, Immunohistopathology, and Toxicity.
Karl V. Clemons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activities of Nine Antifungal Drugs against 81 Phialophora and Cyphellophora Isolates
Peiying Feng et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Molecular Identification and In Vitro Response to Antifungal Drugs of Clinical Isolates of Exserohilum
Keith Cassia da Cunha et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii
Enrique Calvo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Treatment of Refractory Coccidioidomycosis With Voriconazole or Posaconazole
Michelle M. Kim et al.
CLINICAL INFECTIOUS DISEASES (2011)
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis
A. Calcagno et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
The treatment of pulmonary Wangiella dermatitidis infection with oral voriconazole
M. N. Bulloch
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2011)
Extensive long-standing chromomycosis due to Fonsecaea pedrosoi: Three cases with relevant improvement under voriconazole therapy
Paulo Ricardo Criado et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2011)
Melanized Fungi in Human Disease
Sanjay G. Revankar et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Invasive sinonasal disease due to dematiaceous fungi in immunocompromised individuals: case report and review of the literature
Catherine Derber et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Antifungal therapies in murine disseminated phaeohyphomycoses caused by Exophiala species
Enrique Calvo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species
H. Badali et al.
MEDICAL MYCOLOGY (2010)
Posaconazole Therapeutic Drug Monitoring: a Reference Laboratory Experience
George R. Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Comparative Efficacies of Lipid-Complexed Amphotericin B and Liposomal Amphotericin B against Coccidioidal Meningitis in Rabbits
Karl V. Clemons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis
M. Reinwald et al.
BONE MARROW TRANSPLANTATION (2009)
Phaeohyphomycosis in a Tertiary Care Cancer Center
Ronen Ben-Ami et al.
CLINICAL INFECTIOUS DISEASES (2009)
A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever
Michael Ellis et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Paul E. Verweij et al.
LANCET INFECTIOUS DISEASES (2009)
What is the Therapeutic Range for voriconazole?
Russell E. Lewis
CLINICAL INFECTIOUS DISEASES (2008)
Posaconazole concentrations in the central nervous system
Maria J. G. T. Rueping et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection
Robert G. Rivard et al.
MEDICAL MYCOLOGY (2007)
Animal models: an important tool in mycology
Javier Capilla et al.
MEDICAL MYCOLOGY (2007)
Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis
Javier Capilla et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Posaconazole: a new broad-spectrum antifungal agent
Douglas S. Kwon et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis
Perparim Kamberi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis
Karl V. Clemons et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Comparative efficacies of conventional amphotericin B, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis
KV Clemons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Improved outcome in central nervous system aspergillosis, using voriconazole treatment
S Schwartz et al.
BLOOD (2005)
Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole
HM Al-Abdely et al.
MEDICAL MYCOLOGY (2005)
Case study:: Posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera
R Negroni et al.
CLINICAL INFECTIOUS DISEASES (2004)
Efficacy of posaconazole in a murine model of central nervous system aspergillosis
JK Imai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Combinations of antifungal agents in therapy - what value are they?
M Cuenca-Estrella
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Posaconazole therapy of disseminated phaeohyphomycosis in a murine model
JR Graybill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana
A Fica et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
Efficacy of amphotericin B or itraconazole in a murine model of central nervous system Aspergillus infection
TM Chiller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates
AK Zaas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits
KV Clemons et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi:: Report from SENTRY Antimicrobial Surveillance Program, 2000
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Disseminated phaeohyphomycosis: Review of an emerging mycosis
SG Revankar et al.
CLINICAL INFECTIOUS DISEASES (2002)
In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
A Espinel-Ingroff
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Uncommon opportunistic fungi: new nosocomial threats
AH Groll et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Clinical experience with itraconazole in systemic fungal infections
M Boogaerts et al.
DRUGS (2001)
In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature
A Espinel-Ingroff et al.
MYCOPATHOLOGIA (2001)
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia
JR Wingard et al.
CLINICAL INFECTIOUS DISEASES (2000)
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
AH Groll et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis
KN Sorensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum (Ramichloridium mackenziei)
HM Al-Abdely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
